
- Pharmaceutical Technology\'s In the Lab eNewsletter-06-03-2020
 - Volume 15
 - Issue 6
 
New SARS-CoV-2 Molecular Quality Control
The quality control from ZeptoMetrix is formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable.
On May 5, 2020, ZeptoMetrix announced its new, ready-to-use NATtrol, a SARS-CoV-2 molecular quality control for laboratory QC and test validation.
According to a company press release, the quality control is formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable, including:
- NATtrol SARS-CoV-2 Positive Control
 
- Product Number: NATSARS(COV2)-ERC
 
Complementing the release of the positive control is a negative control formulated with human A549 cells:
- NATtrol SARS-CoV-2 Negative Control
 
- Product Number: NATSARS(COV2)-NEG
 
"Due to the unprecedented COVID-19 pandemic, we were tasked to develop and deploy reliable, user-friendly commercial solutions for ready-to-use, non-infectious SARS-CoV-2 full process molecular quality controls under accelerated timelines,” said Shawn R. Smith, president and CEO of ZeptoMetrix, in the press release. “Today, I am extremely proud to announce that ZeptoMetrix has launched such controls - containing purified intact viral particles of actual SARS-CoV-2 that provide laboratories, hospitals and research facilities with essential external run controls to help ensure the reliability of COVID-19 testing.”
	Source: 
Articles in this issue
over 5 years ago
Bio-Rad Launches Anti-Certolizumab Pegol Antibodiesover 5 years ago
Improved Pharma to Expand its Microscopy Servicesover 5 years ago
Good Automation Practices in the Laboratoryover 5 years ago
Contamination Drives a More Concerted Approach to Genotoxinsover 5 years ago
Testing for Nitrosamines in Pharmaceutical Drugsover 5 years ago
Avantor OmniTop Sample Tubes Offers Adjustable Volume SamplingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





